LIXT logo

LIXT Cash From Investing

Annual CFI

N/A

December 31, 2023


Summary


Performance

LIXT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLIXTcash flowmetrics:

Quarterly CFI

N/A

September 30, 2024


Summary


Performance

LIXT Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLIXTcash flowmetrics:

TTM CFI

N/A

September 30, 2024


Summary


Performance

LIXT TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLIXTcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

LIXT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

LIXT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Lixte Biotechnology Holdings Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2016
$104.10 K(-5.0%)
$0.00(-100.0%)
$104.00 K(-80.2%)
Sep 2016
-
$1.05 M(-674.8%)
$524.00 K(+649.6%)
Jun 2016
-
-$183.40 K(-76.1%)
$69.90 K(-84.3%)
Mar 2016
-
-$766.70 K(-282.5%)
$446.00 K(+306.9%)
Dec 2015
$109.60 K(-152.8%)
$420.00 K(-30.0%)
$109.60 K(-70.3%)
Sep 2015
-
$600.00 K(+211.4%)
$369.60 K(+431.0%)
Jun 2015
-
$192.70 K(-117.5%)
$69.60 K(-105.3%)
Mar 2015
-
-$1.10 M(-262.2%)
-$1.31 M(+531.6%)
Dec 2014
-$207.60 K(<-9900.0%)
$680.00 K(+126.7%)
-$207.50 K(-76.6%)
Sep 2014
-
$300.00 K(-125.3%)
-$887.50 K(-25.3%)
Jun 2014
-
-$1.19 M(<-9900.0%)
-$1.19 M(<-9900.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2013
-
$0.00(0.0%)
$75.00 K(-78.3%)
Dec 2012
$345.00 K(-72.4%)
$0.00(0.0%)
$345.00 K(-56.6%)
Sep 2012
-
$0.00(-100.0%)
$795.00 K(-38.6%)
Jun 2012
-
$75.00 K(-72.2%)
$1.29 M(-14.8%)
Mar 2012
-
$270.00 K(-40.0%)
$1.52 M(+21.6%)
Dec 2011
$1.25 M
$450.00 K(-10.0%)
$1.25 M(+25.0%)
Sep 2011
-
$500.00 K(+66.7%)
$999.80 K(+29.2%)
DateAnnualQuarterlyTTM
Jun 2011
-
$300.00 K(>+9900.0%)
$774.10 K(+63.3%)
Mar 2011
-
$0.00(-100.0%)
$474.00 K(-130.1%)
Dec 2010
-$1.58 M(+6204.0%)
$199.80 K(-27.2%)
-$1.58 M(-12.5%)
Sep 2010
-
$274.30 K(<-9900.0%)
-$1.80 M(-13.2%)
Jun 2010
-
-$100.00(-100.0%)
-$2.08 M(+0.0%)
Mar 2010
-
-$2.05 M(+8100.0%)
-$2.08 M(+8200.0%)
Dec 2009
-$25.00 K(<-9900.0%)
-$25.00 K(<-9900.0%)
-$25.00 K(<-9900.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2008
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2008
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2008
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2007
-$300.00(-40.0%)
$0.00(0.0%)
-$300.00(-50.0%)
Sep 2007
-
$0.00(0.0%)
-$600.00(0.0%)
Jun 2007
-
$0.00(-100.0%)
-$600.00(0.0%)
Mar 2007
-
-$300.00(0.0%)
-$600.00(+20.0%)
Dec 2006
-$500.00(<-9900.0%)
-$300.00(<-9900.0%)
-$500.00(+150.0%)
Sep 2006
-
$0.00(0.0%)
-$200.00(0.0%)
Jun 2006
-
$0.00(-100.0%)
-$200.00(0.0%)
Mar 2006
-
-$200.00
-$200.00
Dec 2005
$0.00
-
-

FAQ

  • What is the all time high annual CFI for Lixte Biotechnology Holdings?
  • What is the all time high quarterly CFI for Lixte Biotechnology Holdings?
  • What is the all time high TTM CFI for Lixte Biotechnology Holdings?

What is the all time high annual CFI for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high annual cash flow from investing activities is $1.25 M

What is the all time high quarterly CFI for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high quarterly cash flow from investing activities is $1.05 M

What is the all time high TTM CFI for Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings all-time high TTM cash flow from investing activities is $1.52 M